首页> Oncotarget> Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.

导出 OA

翻译打印收藏纠错

第一作者： Elisa,Rumi

第一单位： Department of Molecular Medicine, University of Pavia, Pavia, Italy.;Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.

作者： Elisa,Rumi ^[1] ; Emanuela,Boveri ^[2] ; Marta,Bellini ^[3] ; Daniela,Pietra ^[4] ; Virginia V,Ferretti ^[3] ; Emanuela,Sant'Antonio ^[5] ; Chiara,Cavalloni ^[1] ; Ilaria C,Casetti ^[3] ; Elisa,Roncoroni ^[4] ; Michele,Ciboddo ^[3] ; Pietro,Benvenuti ^[3] ; Benedetta,Landini ^[4] ; Elena,Fugazza ^[4] ; Daniela,Troletti ^[4] ; Cesare,Astori ^[4] ; Mario,Cazzola ^[1] ; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators

作者单位： Department of Molecular Medicine, University of Pavia, Pavia, Italy.;Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy. ^[1] Anatomic Pathology Section, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy. ^[2] Department of Molecular Medicine, University of Pavia, Pavia, Italy. ^[3] Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy. ^[4] Department of Oncology, Division of Hematology, Ospedale San Luca, Lucca, Italy. ^[5]

关键词 WHO diagnostic criteria myelofibrosis prefibrotic thrombocythemia

DOI 10.18632/oncotarget.21594

PMID 29254200

发布时间 2022-01-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交